New Insight Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Sell
369
-5
-1% -$5.11K 0.13% 82
2026
Q1
$344K Sell
374
-10
-3% -$10.1K 0.12% 86
2025
Q4
$412K Buy
384
+11
+3% +$10.5K 0.15% 81
2025
Q3
$285K Sell
373
-21
-5% -$15.6K 0.11% 94
2025
Q2
$307K Buy
394
+13
+3% +$10.1K 0.13% 86
2025
Q1
$315K Buy
+381
New +$317K 0.14% 77

Other funds holding LLY

New Insight Wealth Advisors's LLY Position: Q2 2026 in Review

New Insight Wealth Advisors reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $5.11K and leaving 369 shares worth $443K. The position accounts for 0.13% of the portfolio, ranked #82.

New Insight Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • New Insight Wealth Advisors held 369 shares of Eli Lilly worth $443K as of Q2 2026.
  • New Insight Wealth Advisors sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.13% of New Insight Wealth Advisors's portfolio in Q2 2026, its #82 holding.
  • New Insight Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on New Insight Wealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.